pcDNA3-S33Y Beta-catenin Citations (44)
Originally described in: Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.Kolligs FT, Hu G, Dang CV, Fearon ER Mol Cell Biol. 1999 Aug . 19(8):5696-706. PubMed
Articles Citing pcDNA3-S33Y Beta-catenin
Showing 1 to 10 of 44 entries
Articles |
---|
Articles |
---|
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition. Gorji-Bahri G, Krishna BM, Hagerling C, Orimo A, Jirstrom K, Papadakos KS, Blom AM. J Transl Med. 2024 Apr 13;22(1):351. doi: 10.1186/s12967-024-05083-0. PubMed |
The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes. Pizzolato G, Moparthi L, Soderholm S, Cantu C, Koch S. J Cell Sci. 2022 Oct 1;135(19):jcs260082. doi: 10.1242/jcs.260082. Epub 2022 Oct 10. PubMed |
Heparanase-Induced Activation of AKT Stabilizes beta-Catenin and Modulates Wnt/beta-Catenin Signaling during Herpes Simplex Virus 1 Infection. Koujah L, Madavaraju K, Agelidis AM, Patil CD, Shukla D. mBio. 2021 Dec 21;12(6):e0279221. doi: 10.1128/mBio.02792-21. Epub 2021 Nov 9. PubMed |
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of beta-catenin and PD-L1. Ma Y, Xia P, Wang Z, Xu J, Zhang L, Jiang Y. Neoplasia. 2021 Sep;23(9):912-928. doi: 10.1016/j.neo.2021.07.004. Epub 2021 Jul 26. PubMed |
Pyrvinium Treatment Confers Hepatic Metabolic Benefits via beta-Catenin Downregulation and AMPK Activation. Zhou S, Obianom ON, Huang J, Guo D, Yang H, Li Q, Shu Y. Pharmaceutics. 2021 Mar 4;13(3). pii: pharmaceutics13030330. doi: 10.3390/pharmaceutics13030330. PubMed |
Activation of Wnt/beta-catenin signaling restores insulin sensitivity in insulin resistant neurons through transcriptional regulation of IRS-1. Tian S, Tan S, Jia W, Zhao J, Sun X. J Neurochem. 2021 May;157(3):467-478. doi: 10.1111/jnc.15277. Epub 2020 Dec 31. PubMed |
Dose-Dependent and Subset-Specific Regulation of Midbrain Dopaminergic Neuron Differentiation by LEF1-Mediated WNT1/b-Catenin Signaling. Nouri P, Gotz S, Rauser B, Irmler M, Peng C, Trumbach D, Kempny C, Lechermeier CG, Bryniok A, Dlugos A, Euchner E, Beckers J, Brodski C, Klumper C, Wurst W, Prakash N. Front Cell Dev Biol. 2020 Oct 26;8:587778. doi: 10.3389/fcell.2020.587778. eCollection 2020. PubMed |
beta-Catenin Preserves the Stem State of Murine Bone Marrow Stromal Cells Through Activation of EZH2. Sen B, Paradise CR, Xie Z, Sankaran J, Uzer G, Styner M, Meyer M, Dudakovic A, van Wijnen AJ, Rubin J. J Bone Miner Res. 2020 Jun;35(6):1149-1162. doi: 10.1002/jbmr.3975. Epub 2020 Feb 24. PubMed |
beta-Catenin stabilization in NOD dendritic cells increases IL-12 production and subsequent induction of IFN-gamma-producing T cells. Zirnheld AL, Villard M, Harrison AM, Kosiewicz MM, Alard P. J Leukoc Biol. 2019 Dec;106(6):1349-1358. doi: 10.1002/JLB.3A0919-244R. Epub 2019 Sep 30. PubMed |
Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/beta-Catenin Signaling in Ovarian Cancer. Ruan X, Liu A, Zhong M, Wei J, Zhang W, Rong Y, Liu W, Li M, Qing X, Chen G, Li R, Liao Y, Liu Q, Zhang X, Ren D, Wang Y. Mol Ther Oncolytics. 2019 Apr 19;14:94-106. doi: 10.1016/j.omto.2019.04.002. eCollection 2019 Sep 27. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.